Validation of a novel diagnostic tool for decreased tongue pressure
Imamura, Yoshiki, Chebib, Najla, Ohta, Midori, Maria Schulte‐Eickhoff, Regina, Mekki, Mustapha, Schimmel, Martin, Arakawa, Itsuka, Graf, Christophe, Sato, Yuji, Müller, Frauke
Published in Journal of oral rehabilitation (01.11.2021)
Published in Journal of oral rehabilitation (01.11.2021)
Get full text
Journal Article
Masticatory performance in oral function assessment: Alternative methods
Imamura, Yoshiki, Chebib, Najla, Ohta, Midori, Mojon, Philippe, Schulte‐Eickhoff, Regina Maria, Schimmel, Martin, Graf, Christophe, Sato, Yuji, Müller, Frauke
Published in Journal of oral rehabilitation (01.05.2023)
Published in Journal of oral rehabilitation (01.05.2023)
Get full text
Journal Article
Oral function and nutritional status in non‐acute hospitalised elders
Ohta, Midori, Imamura, Yoshiki, Chebib, Najla, Schulte‐Eickhoff, Regina Maria, Allain, Sandrine, Genton, Laurence, Mojon, Philippe, Graf, Christophe, Ueda, Takayuki, Müller, Frauke
Published in Gerodontology (01.03.2022)
Published in Gerodontology (01.03.2022)
Get full text
Journal Article
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial
Christopoulos, Petros, Bozorgmehr, Farastuk, Brückner, Lena, Chung, Inn, Krisam, Johannes, Schneider, Marc A, Stenzinger, Albrecht, Eickhoff, Regina, Mueller, Daniel W, Thomas, Michael
Published in BMC cancer (28.06.2021)
Published in BMC cancer (28.06.2021)
Get full text
Journal Article
The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer
Eichbaum, Michael, Mayer, Christine, Eickhoff, Regina, Bischofs, Esther, Gebauer, Gerhard, Fehm, Tanja, Lenz, Florian, Fricke, Hans-Christian, Solomayer, Erich, Fersis, Nikos, Schmidt, Marcus, Wallwiener, Markus, Schneeweiss, Andreas, Sohn, Christof
Published in BMC cancer (20.10.2011)
Published in BMC cancer (20.10.2011)
Get full text
Journal Article
Ribosomal Protein S19 Interacts with Macrophage Migration Inhibitory Factor and Attenuates Its Pro-inflammatory Function
Filip, Ana-Maria, Klug, Jörg, Cayli, Sevil, Fröhlich, Suada, Henke, Tamara, Lacher, Philipp, Eickhoff, Regina, Bulau, Patrick, Linder, Monika, Carlsson-Skwirut, Christine, Leng, Lin, Bucala, Richard, Kraemer, Sandra, Bernhagen, Jürgen, Meinhardt, Andreas
Published in The Journal of biological chemistry (20.03.2009)
Published in The Journal of biological chemistry (20.03.2009)
Get full text
Journal Article
Purification and characterization of macrophage migration inhibitory factor as a secretory protein from rat epididymis: evidences for alternative release and transfer to spermatozoa
Eickhoff, R, Wilhelm, B, Renneberg, H, Wennemuth, G, Bacher, M, Linder, D, Bucala, R, Seitz, J, Meinhardt, A
Published in Molecular medicine (Cambridge, Mass.) (01.01.2001)
Published in Molecular medicine (Cambridge, Mass.) (01.01.2001)
Get full text
Journal Article
ADJUBIL: A phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in adjuvant situation for biliary tract cancer
Goetze, Thorsten, Eickhoff, Regina, Pons, Miriam, Kochen, Lisa, Vortmeyer, Doerthe, Al-Batran, Salah-Eddin, Habibzade, Timursah, Adler, Marius, Gonzalez-Carmona, Maria A, Ettrich, Thomas Jens, Koehne, Claus-Henning, Pink, Daniel, van Boemmel, Florian, Pession, Ursula, Wehler, Thomas, Modest, Dominik Paul
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article
Open-label, phase I study evaluating feasibility and safety of subcutaneous IMP321 (LAG-3Ig fusion protein, eftilagimod alpha) combined with avelumab in advanced stage solid tumor entities: Results from stratum D of the INSIGHT platform trial
Goetze, Thorsten Oliver, Mueller, Daniel Wilhelm, Rafiyan, Mohammad-Reza, Kiselicki, Dragan, Eickhoff, Regina, Jaeger, Elke, Al-Batran, Salah-Eddin
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Phase I INSIGHT platform trial: Advanced safety and efficacy data from stratum D evaluating feasibility and safety of eftilagimod alpha (soluble LAG-3 protein) combined with avelumab in advanced solid tumors
Goetze, Thorsten Oliver, Mueller, Daniel Wilhelm, Rafiyan, Mohammad-Reza, Kiselicki, Dragan, Habibzade, Timursah, Schaaf, Marina, Eickhoff, Regina, Jäger, Elke, Al-Batran, Salah-Eddin
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
The "INSIGHT" trial: An explorative, open-labeled phase I study to evaluate the feasibility and safety of intra-tumoral, intra-peritoneal, and subcutaneous injections with IMP321 (LAG-3Ig fusion protein) for advanced stage solid tumor entities
Mueller, Daniel Wilhelm, Goetze, Thorsten Oliver, Eickhoff, Regina, Reichart, Alexander, Al-Batran, Salah-Eddin
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC)
Vogel, Arndt, Waidmann, Oliver, Müller, Tobias, Siegler, Gabriele Margareta, Goetze, Thorsten Oliver, De Toni, Enrico N., Gonzalez-Carmona, Maria A, Hausner, Guido, Geissler, Michael, Fischer von Weikersthal, Ludwig, Kestler, Angelika M. R., Finkelmeier, Fabian, Kleiß, Matthias, Marquardt, Jens U., Teufel, Andreas, Klagges, Jorge, Eickhoff, Regina, Al-Batran, Salah-Eddin, Saborowski, Anna Lena
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC)
Vogel, Arndt, Goetze, Thorsten Oliver, Hausner, Guido, Geißler, Michael, Siegler, Gabriele Margareta, Fischer von Weikersthal, Ludwig, Kestler, Angelika M. R., Kleiß, Matthias, Müller, Tobias, Teufel, Andreas, Marquardt, Jens, Gonzalez-Carmona, Maria A, Mueller, Daniel Wilhelm, Eickhoff, Regina, de Toni, Enrico N., Waidmann, Oliver, Al-Batran, Salah-Eddin
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
The "INSIGHT" Trial: Two new strata of an explorative, open-labeled phase I study evaluating the feasibility and safety of subcutaneous IMP321 injections (LAG-3Ig fusion protein, eftilagimod alpha) combined with either standard-of-care drug therapy or PD-L1 inhibition (avelumab) in advanced-stage solid tumor entities
Mueller, Daniel Wilhelm, Goetze, Thorsten Oliver, Atmaca, Akin, Rafiyan, Mohammad-Reza, Weidmann, Eckhart, Brandts, Christian H., Pabst-Giger, Urs, Duex, Markus, Kraus, Thomas Werner, Stahn, Simon, Eickhoff, Regina, Al-Batran, Salah-Eddin
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Influence of macrophage migration inhibitory factor (MIF) on the zinc content and redox state of protein-bound sulphydryl groups in rat sperm: indications for a new role of MIF in sperm maturation
Eickhoff, Regina, Baldauf, Christina, Koyro, Hans-Werner, Wennemuth, Gunther, Suga, Yasushi, Seitz, Jürgen, Henkel, Ralf, Meinhardt, Andreas
Published in Molecular human reproduction (01.08.2004)
Published in Molecular human reproduction (01.08.2004)
Get full text
Journal Article